Haleon (HLN) Stock Forecast & Price Target

$10.67

+0.08 (+0.76%)

(As of 09/27/2024 ET)

Haleon - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 5 Analyst Ratings

Sell
0

Hold
1

Buy
4

Based on 5 Wall Street analysts who have issued ratings for Haleon in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 5 analysts, 1 has given a hold rating, and 4 have given a buy rating for HLN.

Consensus Price Target

$10.95
2.62% Upside

According to the 5 analysts' twelve-month price targets for Haleon, the average price target is $10.95. The highest price target for HLN is $10.95, while the lowest price target for HLN is $10.95. The average price target represents a forecasted upside of 2.62% from the current price of $10.67.

Get the Latest News and Ratings for HLN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Haleon and its competitors.

HLN Analyst Ratings Over Time

Type	Current Forecast 9/30/23 to 9/29/24	1 Month Ago 8/31/23 to 8/30/24	3 Months Ago 7/2/23 to 7/1/24	1 Year Ago 9/30/22 to 9/30/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)	4 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$10.95	N/A	N/A	N/A
Forecasted Upside	2.62% Upside	N/A	N/A	N/A
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

WARNING: “Buffett Indicator” flashing for first time in 50 years (Ad)

The stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future.

Take these 4 steps today to protect your retirement NOW

HLN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

HLN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Haleon Stock vs. The Competition

Type	Haleon	Medical Companies	S&P 500
Consensus Rating Score	2.80	2.78	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	2.62% Upside	818.50% Upside	6.16% Upside
News Sentiment Rating	Positive News See Recent HLN News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/20/2024	Morgan Stanley 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$9.90 ➝ $10.95	+4.78%
8/6/2024	Berenberg Bank 2 of 5 stars	B. Davies Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy
8/6/2024	The Goldman Sachs Group 2 of 5 stars	O. Nicolai Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
4/17/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy
3/26/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy
8/8/2023	Investec Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Sell ➝ Hold
5/24/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold
4/4/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform
1/31/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		GBX 360 ➝ GBX 364

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 11:26 AM ET.

Should I Buy Haleon Stock? HLN Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, September 19, 2024. Please send any questions or comments about these Haleon pros and cons to contact@marketbeat.com.

Haleon
Bull Case

Here are some ways that investors could benefit from investing in Haleon plc:

Haleon plc has a strong market cap of $45.07 billion, indicating stability and potential for growth.
The company has a consistent return on equity of 19.85%, showcasing efficient use of shareholder funds.
Despite missing earnings estimates by $0.01, Haleon plc has a positive net margin of 9.71%, demonstrating profitability.
Analysts have given Haleon plc an average rating of "Moderate Buy," suggesting positive sentiment and growth prospects.
With a dividend yield of 1.6% and a payout ratio of 33.33%, Haleon plc offers investors a steady income stream.

Haleon
Bear Case

Investors should be bearish about investing in Haleon plc for these reasons:

Haleon plc's PEG ratio of 2.69 indicates that the stock may be overvalued relative to its earnings growth potential.
The company's price-to-earnings ratio of 32.90 suggests that the stock may be trading at a premium compared to industry peers.
Despite a positive net margin, Haleon plc missed earnings estimates, which could raise concerns about future performance.
The beta of 0.24 indicates that Haleon plc is less volatile than the market, potentially limiting short-term trading opportunities.
While the company has a strong market cap, the stock's 50-day moving average of $9.07 is higher than the 200-day moving average of $8.60, signaling potential short-term price volatility.

HLN Forecast - Frequently Asked Questions

: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Haleon is $10.95, with a high forecast of $10.95 and a low forecast of $10.95.
: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last year. There is currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" HLN shares.
: According to analysts, Haleon's stock has a predicted upside of 2.62% based on their 12-month stock forecasts.
: Over the previous 90 days, Haleon's stock had 1 downgrade by analysts.
: Haleon has been rated by research analysts at Berenberg Bank, Morgan Stanley, and The Goldman Sachs Group in the past 90 days.
: Analysts like Haleon more than other "medical" companies. The consensus rating score for Haleon is 2.80 while the average consensus rating score for "medical" companies is 2.78. Learn more on how HLN compares to other companies.

Stock Forecasts and Research Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

WARNING: “Buffett Indicator” flashing for first time in 50 years (Ad)

Take these 4 steps today to protect your retirement NOW

This page (NYSE:HLN) was last updated on 9/29/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Haleon (HLN) Stock Forecast & Price Target